AtaiBeckley ATAI
NASDAQ ATAI
$7.34 -0.01 (-0.07%)
As of: Sep 4, 2026 · 1:34 PM EDT

AtaiBeckley (ATAI) EBITDA (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly EBITDA of -$30.9 million for Q1 2026, down 51.7% year-over-year from -$64.0 million in Q1 2025, and down 51.7% quarter-over-quarter from -$20.4 million in Q1 2025.

Analysis

AtaiBeckley (ATAI) EBITDA (2020 - 2026) Analysis & Trends

AtaiBeckley has reported EBITDA for 6 years, with the latest figure at -$28.4 million in Q3 2025.

  • Quarterly EBITDA fell 25.81% year-over-year to -$28.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$104.3 million (up 1.54% YoY) and the FY2024 annual result came in at -$102.7 million, up 18.16% from the prior year.
  • EBITDA for Q1 2026 stood at -$30.9 million, down from -$20.4 million in the prior quarter.
  • The five-year high for EBITDA was -$20.4 million in Q1 2025, with the low at -$30.9 million in Q1 2026.
  • A 5-year average of -$30.7 million and a median of -$31.9 million in 2023 frame the typical range for EBITDA.
  • The widest YoY moves for EBITDA: up 48.22% in 2021, down 952.69% in 2021.
  • Over 5 years, EBITDA stood at -$45.2 million in 2021, then rose by 16.85% to -$37.6 million in 2022, then gained by 10.66% to -$33.6 million in 2023, then rose by 9.82% to -$30.3 million in 2024, then increased by 6.04% to -$28.4 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods registered -$28.4 million, -$25.3 million, and -$20.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -505.13 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 133.12 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -1.55 Mn
10 AtaiBeckley 1.60 Bn 1.60 Bn - -28.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.14 Mn
Mar 31, 2026 -30.90 Mn
Sep 30, 2025 -28.44 Mn
Jun 30, 2025 -25.27 Mn
Jun 30, 2025 -25.27 Mn
Mar 31, 2025 -20.37 Mn
Mar 31, 2025 -20.37 Mn
Dec 31, 2024 -30.27 Mn
Sep 30, 2024 -22.60 Mn
Jun 30, 2024 -25.73 Mn
Mar 31, 2024 -24.09 Mn
Dec 31, 2023 -33.56 Mn
Sep 30, 2023 -26.83 Mn
Jun 30, 2023 -31.86 Mn
Mar 31, 2023 -33.21 Mn
Dec 31, 2022 -37.57 Mn
Sep 30, 2022 -38.42 Mn
Jun 30, 2022 -35.36 Mn
Mar 31, 2022 -33.44 Mn
Dec 31, 2021 -45.18 Mn